Results 121 to 130 of about 80,877 (282)
Abstract Background/aims Take‐home naloxone (THN) programmes have been introduced in many European countries to provide non‐medically trained people who are likely to witness an opioid overdose, including people who use opioids, with a naloxone kit and training.
Nicola Metrebian +31 more
wiley +1 more source
Layperson Naloxone Education [PDF]
The Centers for Disease Control and Prevention (CDC) announced that the opioid overdose crisis is now a nationwide epidemic, with over 60% of overdoses being unintentional.
Noyes, Tiffany
core
Administering naloxone during COVID-19. Spanish [PDF]
Title from PDF caption (viewed on August 31, 2020)."OHA 2716 SPANISH (08/13/2020)"--Running footer.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.
core
Take-home naloxone and the politics of care.
'Take-home naloxone' refers to a life-saving intervention in which a drug (naloxone) is made available to nonmedically trained people for administration to other people experiencing an opioid overdose.
A. Farrugia +6 more
semanticscholar +1 more source
Abstract Background and Objectives Readmission to residential treatment increases healthcare costs, strains publicly funded systems, and may not adequately meet clients' needs. This study examined rates and predictors of readmission to residential treatment among clients transitioned from detoxification services.
Abreham Mekonnen
wiley +1 more source
Naloxone Nasal Spray Co-Prescription for the Prevention of Opioid Overdose Complications [PDF]
Background: Opioid overdose is becoming a global epidemic. According to Centers for Disease Control and Prevention (CDC), 67,367 drug overdose deaths occurred in the United States (US) in 2018.
NC DOCKS at East Carolina University +1 more
core
Abstract Opioids are prescribed widely for chronic pain despite well‐recognised risks and variable long‐term benefit, reflecting the lack of effective alternatives for many patients. Combination therapies offer a promising strategy to enhance efficacy whilst reducing side effects.
André Mouraux +26 more
wiley +1 more source
Background and aims:Opioid-related overdose death rates continue to rise in the United States, especially in racial/ethnic minority communities. Our objective was to determine if US municipalities with high percentages of non-white residents have ...
core
Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states [PDF]
Objectives Little is known about attitudes of pharmacists and consumers to pharmacy naloxone. We examined perceptions and experiences of pharmacy naloxone from people with opioid use disorder, patients taking chronic opioids for pain, caregivers of ...
Potter, Nathan +19 more
core +1 more source
Background Pharmacists are on the frontline caring for patients at risk of an opioid overdose and for patients with an opioid use disorder (OUD). Dispensing naloxone and medications for OUD and counseling patients about these medications are ways ...
A. Muzyk +4 more
semanticscholar +1 more source

